Market closedNon-fractional
Kiniksa Pharmaceuticals/KNSA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Kiniksa Pharmaceuticals
Ticker
KNSA
Sector
Trading on
NASDAQ
Industry
Headquarters
-
Employees
-
KNSA Metrics
BasicAdvanced
-
Market cap
-
P/E ratio
-
EPS
-
Beta
-
Dividend rate
Price and volume
Financial strength
Management effectiveness
Valuation
Growth
KNSA News
AllArticlesVideos
Kiniksa Pharmaceuticals: Improved Outlook For Arcalyst After Q2 Beat
Seeking Alpha·3 days ago
Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2024 Earnings Call Transcript
Seeking Alpha·4 days ago
Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution
GlobeNewsWire·4 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Kiniksa Pharmaceuticals stock?
Kiniksa Pharmaceuticals (KNSA) has a market cap of $0 as of July 27, 2024.
What is the P/E ratio for Kiniksa Pharmaceuticals stock?
The price to earnings (P/E) ratio for Kiniksa Pharmaceuticals (KNSA) stock is 0 as of July 27, 2024.
Does Kiniksa Pharmaceuticals stock pay dividends?
Yes, the Kiniksa Pharmaceuticals (KNSA) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $ and the yield is 0%. Kiniksa Pharmaceuticals has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Kiniksa Pharmaceuticals dividend payment date?
The next Kiniksa Pharmaceuticals (KNSA) dividend payment date is unconfirmed.
What is the beta indicator for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals (KNSA) does not currently have a Beta indicator.
Buy or sell Kiniksa Pharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.